Preventive Measures for Individuals with a Family History of Brain Aneurysm

Risk Assessment

The American Heart Association indicates that family history significantly increases the risk of harboring an unruptured intracranial aneurysm, with prevalence ratios indicating an increased risk between 1.9% and 5.9% compared to the general population 1
The American Stroke Association suggests that the risk is particularly elevated in individuals with multiple affected family members - having three or more affected relatives triples the risk of subarachnoid hemorrhage 2
First-degree relatives of those with familial intracranial aneurysm syndrome have approximately 8% risk of harboring an unruptured aneurysm with a relative risk of 4.2 3

The American College of Cardiology recommends strong screening in individuals with two or more first-degree relatives with history of aneurysmal subarachnoid hemorrhage (aSAH) or unruptured intracranial aneurysm (Class I; Level of Evidence B) 4
For individuals with one first-degree relative with history of brain aneurysm, screening should be considered, especially with additional risk factors 4
The American Heart Association suggests that screening is particularly important for those with additional risk factors that increase likelihood of aneurysm detection, including higher lipid levels and higher fasting glucose 4

The American College of Radiology recommends MRA without contrast as the preferred initial screening method with sensitivity rates of 69-93% for aneurysms >3-5mm 4
The American College of Radiology suggests that CT angiography is an acceptable alternative with sensitivities of 77-97% for aneurysms as small as 2-3mm 4

The American Heart Association recommends smoking cessation as critical, as smoking is one of the strongest modifiable risk factors for aneurysm formation and rupture 4
The American Stroke Association suggests that blood pressure control is essential, as hypertension is a major risk factor for hemorrhagic stroke, and antihypertensive medication reducing diastolic blood pressure by an average of 6 mm Hg has been shown to produce a 42% reduction in stroke incidence 2
The American Stroke Association recommends avoiding sympathomimetic drugs, including cocaine and phenylpropanolamine, which have been implicated as causes of subarachnoid hemorrhage 3
The American Heart Association suggests limiting alcohol consumption, as heavy alcohol use is an independent risk factor for subarachnoid hemorrhage 2

The American Stroke Association indicates that individuals who have been previously treated for aneurysms require particularly vigilant follow-up, as they have a higher risk (relative risk 5.5) of developing new aneurysms, and the annual rate of new aneurysm formation in patients previously treated for a ruptured aneurysm is 1-2% per year 2
The American Heart Association suggests that women have a higher incidence of aneurysmal subarachnoid hemorrhage compared to men (1.24 times higher) 5

The American Stroke Association recommends that certain genetic syndromes are associated with increased risk of aneurysm formation and should prompt more aggressive screening, including Autosomal dominant polycystic kidney disease 3, Type IV Ehlers-Danlos syndrome 2, Marfan syndrome 1, Coarctation of the aorta 1, Bicuspid aortic valve 1, and other rare conditions including neurofibromatosis type 1, tuberous sclerosis, and Noonan syndrome 1

The American College of Cardiology recommends screening every 5 to 7 years with MRA for individuals with ≥2 first-degree relatives with cerebral aneurysms or aneurysmal subarachnoid hemorrhage, from age 20 to 80 years, as this interval is cost-effective and captures the substantial yield of new aneurysm formation (Class I recommendation) 6, 7
For individuals with ≥2 affected first-degree relatives, long-term data demonstrates aneurysms detected in 11% at first screening, although the specific percentages at subsequent screenings are not cited here 6
The American Heart Association suggests that individuals with 1 first-degree relative with aneurysm should consider screening, particularly with additional risk factors, and use the same 5-7 year interval if screening is initiated 8
For individuals with autosomal dominant polycystic kidney disease (ADPKD), screening every 5-7 years is recommended given the 10-11.5% prevalence of aneurysms, and screening is considered cost-effective in multiple studies 9, 10

The American College of Radiology recommends MRA without contrast as the first-line screening tool, with sensitivity 95% and specificity 89% for aneurysm detection, and it is non-invasive with no radiation exposure, making it ideal for serial screening 9, 10
CTA is an acceptable alternative with sensitivity >90% for aneurysm detection, although it involves ionizing radiation, making it less appealing for repeated lifetime surveillance 9, 11
Catheter angiography should be reserved for symptomatic patients, questionable MRA or CTA findings, due to its invasive nature and 0.1% complication risk 8, 11

Screening should continue until age 65-80 years, as recommended by the American College of Cardiology 6

Growing aneurysms have an 18.5% annual hemorrhage rate compared to 0.2% for stable aneurysms in patients with a family history of intracranial aneurysm 12
Treatment should be offered for documented enlargement in the absence of prohibitive comorbidities, as recommended by the American Heart Association (Class I recommendation) 12

MRA without contrast has 95% sensitivity and 89% specificity for aneurysm detection, making it the optimal choice for serial surveillance 12
MRA detects aneurysms ≥3-5mm with sensitivity rates of 69-93% in patients with a family history of intracranial aneurysm 12

Smoking cessation is critical, as smoking is one of the strongest modifiable risk factors for both aneurysm formation and rupture, according to the American College of Cardiology 12
Blood pressure control is essential, as reducing diastolic blood pressure by 6 mmHg produces a 42% reduction in stroke incidence in patients with a family history of intracranial aneurysm 12